Jane Street
ADMA icon

Jane Street’s ADMA Biologics ADMA Stock Holding History

Jane Street’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$534K Sell
63,800
-531,600
-89% -$4.85M ﹤0.01% 7862
2026
Q1 		$5.36M Buy
595,400
+318,900
+115% +$5.03M ﹤0.01% 3404
2025
Q4 		$5.04M Sell
276,500
-7,700
-3% -$130K ﹤0.01% 3214
2025
Q3 		$4.17M Buy
284,200
+47,300
+20% +$811K ﹤0.01% 3691
2025
Q2 		$4.31M Sell
236,900
-155,600
-40% -$3.17M ﹤0.01% 3203
2025
Q1 		$7.79M Buy
392,500
+266,800
+212% +$4.61M ﹤0.01% 2316
2024
Q4 		$2.16M Buy
125,700
+72,900
+138% +$1.37M ﹤0.01% 3978
2024
Q3 		$1.06M Buy
52,800
+1,000
+2% +$15.6K ﹤0.01% 5779
2024
Q2 		$579K Buy
51,800
+9,200
+22% +$77.2K ﹤0.01% 6768
2024
Q1 		$281K Buy
42,600
+28,300
+198% +$155K ﹤0.01% 7662
2023
Q4 		$64.6K Sell
14,300
-4,800
-25% -$17.8K ﹤0.01% 8714
2023
Q3 		$68.4K Sell
19,100
-85,000
-82% -$327K ﹤0.01% 8077
2023
Q2 		$384K Buy
104,100
+5,500
+6% +$20.4K ﹤0.01% 6722
2023
Q1 		$326K Sell
98,600
-300,000
-75% -$1.04M ﹤0.01% 7054
2022
Q4 		$1.55M Buy
398,600
+305,500
+328% +$942K ﹤0.01% 4268
2022
Q3 		$226K Buy
93,100
+58,500
+169% +$140K ﹤0.01% 7985
2022
Q2 		$69K Buy
+34,600
New +$68.1K ﹤0.01% 8810
2022
Q1 		– Sell
-13,900
Closed -$20K – 10188
2021
Q4 		$20K Buy
+13,900
New +$18.3K ﹤0.01% 9790
2020
Q3 		– Sell
-10,400
Closed -$30K – 7074
2020
Q2 		$30K Buy
+10,400
New +$29.9K ﹤0.01% 6935

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Jane Street's ADMA Position: Q2 2026 in Review

Jane Street reduced its ADMA Biologics (ADMA) stake by 78% in Q2 2026, selling an estimated $21.8M and leaving 662,082 shares worth $5.54M. The position accounts for ﹤0.01% of the portfolio, ranked #3563.

Jane Street first reported a position in ADMA in Q1 2019 and has held it in 26 quarters since. The position peaked at $27.5M in Q1 2026. 322 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Jane Street held 662,082 shares of ADMA Biologics worth $5.54M as of Q2 2026.
  • Jane Street sold 2,389,861 ADMA Biologics shares in Q2 2026, an estimated $21.8M.
  • ADMA Biologics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #3563 holding.
  • Jane Street first reported a position in ADMA Biologics in Q1 2019 and has held it in 26 quarters since.
  • Jane Street's ADMA Biologics position peaked at $27.5M in Q1 2026.
  • 322 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.